Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients-Reference-Cited by-同舟云学术

Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients

Published:2006-09-07 Issue:05 Volume:10 Page:
ISSN:1461-1457
Container-title:The International Journal of Neuropsychopharmacology
language:en
Short-container-title:Int. J. Neuropsychopharm.

Author:

Zai Clement C.,Hwang Rudi W.,De Luca Vincenzo,Müller Daniel J.,King Nicole,Zai Gwyneth C.,Remington Gary,Meltzer Herbert Y.,Lieberman Jeffrey A.,Potkin Steven G.,Kennedy James L.

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Psychiatry and Mental health,Pharmacology

Link

http://academic.oup.com/ijnp/article-pdf/10/5/639/1811641/10-5-639.pdf

Reference89 articles.

1. Conventional vs. Newer Antipsychotics in Elderly Patients

2. Homozygosity for the Gly-9 variant of the dopamine D3 receptor and risk for tardive dyskinesia in schizophrenic patients

3. Association between the Ser9Gly Polymorphism of the Dopamine D3 Receptor Gene and Tardive Dyskinesia in Chinese Schizophrenic Patients

4. Pharmacogenetics of Tardive Dyskinesia Combined Analysis of 780 Patients Supports Association with Dopamine D3 Receptor Gene Ser9Gly Polymorphism

5. Plasma glycine and serine levels in schizophrenia compared to normal controls and major depression: relation to negative symptoms

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of schizophrenia‐associated genetic markers in the HLA region as risk factors for tardive dyskinesia;Human Psychopharmacology: Clinical and Experimental;2024-04-27

2. Genetic Factors Associated With Tardive Dyskinesia: From Pre-clinical Models to Clinical Studies;Frontiers in Pharmacology;2022-01-24

3. Pharmacogenomics and antipsychotics: efficacy and adverse drug reactions;Psychiatric Genomics;2022

4. Candidate Genes Encoding Dopamine Receptors as Predictors of the Risk of Antipsychotic-Induced Parkinsonism and Tardive Dyskinesia in Schizophrenic Patients;Biomedicines;2021-07-23

5. Liver enzyme CYP2D6 gene and tardive dyskinesia;Pharmacogenomics;2020-10